OTC: PPTDF - PeptiDream Inc.

Yield per half year: 0%
Dividend yield: 0.00%
Sector: Healthcare

Share chart PeptiDream Inc.


About PeptiDream Inc.

PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug finding platform for the development of peptides. It has a collaborative research and exclusive license agreement with Takeda Pharmaceutical Company Limited to develop peptide drug conjugates for neuromuscular diseases. The company was incorporated in 2006 and is headquartered in Kawasaki, Japan.


Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.peptidream.com
Цена ао 17
Change price per year: +78.95% (9.5)
Change price per 3 year: -62.5% (45.33)

Underestimation

Title Value Grade
P/S 5.5 2
P/BV 0.0278 10
P/E 52.04 3
EV/EBITDA 20.63 5
Total: 6.25

Efficiency

Title Value Grade
ROA, % 0.031 1
ROE, % 0.0533 1
Total: 2.67

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0.8871

Debt

Title Value Grade
Debt/EBITDA 288.25 0
Total: 3.8

Growth impulse

Title Value Grade
Yield Revenue, % -96.3 0
Yield Ebitda, % -97.95 0
Yield EPS, % -37.17 0
Total: 2



Head Job title Payment Year of birth
Dr. Patrick Crawford Reid Ph.D. President, CEO & Representative Director 1.01M 1975 (50 years)
Dr. Kiyofumi Kaneshiro Ph.D. CFO, Executive VP & Director 1.01M 1977 (48 years)
Dr. Keiichi Masuya Ph.D. COO, Executive VP & Director 1.01M 1969 (56 years)
Yuko Okimoto IR & Public Relations Director N/A
Masato Murakami M.B.A., M.D., Ph.D. Chief Medical Officer N/A
Mr. Christian Cunningham Ph.D. Chief Scientific Officer N/A

Address: Japan, Kawasaki -, 3-25-23 Tonomachi - open in Google maps, open in Yandex maps
Website: https://www.peptidream.com